On September 11, 2023, the FDA approved updated COVID-19 vaccines from Pfizer and Moderna
The authorization extended to individuals aged 6 months and older, as recommended by the ACIP on September 12
The CDC Director adopted the ACIP's recommendation on the same day
This approval marked the first instance of COVID-19 vaccines transitioning to the commercial market
Previously, the federal government had provided vaccines free of charge to all, regardless of insurance or financial status
Pfizer and Moderna are charging $115 and $128 per dose, respectively, in the commercial market
These prices are approximately 3-4 times higher than what the federal government paid
Additional costs may apply for vaccine administration and provider visits
Insurance market rules will now dictate how COVID-19 vaccines are paid for and covered
Due to the Affordable Care Act and pandemic-related laws, vaccines will remain free for most individuals with insurance, but uninsured adults may not have guaranteed free access